Using cutting-edge, proprietary genomic technologies, Verenium discovers and optimizes novel protein-based products. We tap into diverse ecosystems, such as volcanoes, rain forests, and deep sea hydrothermal vents to collect DNA from the microorganisms that dwell there. We mine our collection of billions of microbial genes using our suite of advanced robotic screening systems to identify product candidates that can be optimized for commercial use by applying our industry-leading laboratory evolution platform, called DirectEvolution® technology. By combining discovery with laboratory evolution technologies, Verenium has successfully commercialized and developed a robust collection of enzyme products.
The same laboratory evolution techniques that allow us to improve enzymes also enables optimization of therapeutic proteins such as antibodies. Verenium uses this platform, called MedEv™ medicinal evolution technology, to optimize candidate antibodies for key partners.
With our suite of patented and proprietary technologies, Verenium is well-positioned to meet the unique product demands for the biofuels, specialty industrial processes and health & nutrition markets.
